Boston Scientific’s Farapulse PFA system receives approval in Japan
The Farapulse PFA system provides a non-thermal approach for ablating heart tissue related to atrial fibrillation.
Nasdaq26d
Boston Scientific: Why This MedTech Giant Isn’t Slowing Down
Boston Scientific announced its acquisition of ... markets and, notably, its WATCHMAN device in its structural heart portfolio. EP helps to identify irregular heart rhythms and delivers energy ...
The Lufkin Daily News16d
Groundbreaking LAAO procedure performed in East Texas
A medical milestone has been achieved in Deep East Texas as the first Left Atrial Appendage Occlusion (LAAO) procedure ...
Pharmabiz14d
Boston Scientific gets PDMA approval in Japan for FARAPULSE PFA System
Boston Scientific gets PDMA approval in Japan for FARAPULSE PFA System: Marlborough, Massachusetts Monday, September 30, 2024, 13:00 Hrs [IST] Boston Scientific Corporation, a glo ...
Boston Scientific Receives Japanese Regulatory Approval For The FARAPULSETM Pulsed Field Ablation System
Boston Scientific Corporation (NYSE: BSX ) announced it has received Pharmaceuticals and Medical Device Agency (PMDA) approval in Japan for the FARAPULSETM Pulsed Field Ablation (PFA) System. The ...
BSX Stock Gains From FARAPULSE PFA's PMDA Approval in Japan
Boston Scientific achieves PMDA approval for its FARAPULSE PFA System in Japan. The company expects to launch the system in the country in the upcoming weeks.
Morningstar16d
Boston Scientific Receives Japanese Regulatory Approval for the FARAPULSE™ Pulsed Field Ablation System
27, 2024 /PRNewswire/ -- Boston Scientific Corporation ... PFA System for cardiac ablation and the WATCHMAN FLX™ Pro Left Atrial Appendage Closure Device. Boston Scientific plans to launch ...